| 2000 |
RAB6B is a Rab6 subfamily member that localizes to the Golgi apparatus and ERGIC-53-positive vesicles. It displays lower GTP-binding activity compared to Rab6A, and in overexpression distributes over both Golgi and ER membranes. The GTP-bound form (Q72L mutant) interacts with all known Rab6A effectors including Rabkinesin-6, suggesting a role in retrograde membrane traffic at the Golgi complex. |
cDNA cloning, immunofluorescence, northern blot, GTP-binding assays, overexpression of constitutively active mutant, co-localization studies |
Journal of cell science |
High |
10893188
|
| 2006 |
Crystal structures of human neuronal RAB6B solved in the inactive (MgGDP-bound) and active (MgGTPγS-bound) forms at 2.3 Å and 1.8 Å resolution, respectively. Conformational changes between states occur mainly in switch I and switch II regions, and an additional change is observed in the Rab6 subfamily-specific RabSF3 region, which may contribute to effector specificity. |
X-ray crystallography |
Acta crystallographica. Section D, Biological crystallography |
High |
16790928
|
| 2007 |
RAB6B interacts with Bicaudal-D1 (BICD1) in its GTP-bound (active) form, as shown by yeast two-hybrid, co-immunoprecipitation, and pull-down assays. RAB6B and BICD1 co-localize at the Golgi and along microtubule-aligned vesicles, and both co-localize with dynein in neurites of SK-N-SH neuronal cells. Live imaging showed bi-directional movement of EGFP-RAB6B structures in neurites, indicating RAB6B links to the dynein/dynactin complex via BICD1 to regulate retrograde transport in neuronal cells. |
Yeast two-hybrid, co-immunoprecipitation, pull-down assay, confocal microscopy, live-cell imaging |
Experimental cell research |
High |
17707369
|
| 2008 |
RAB6B interacts with the dynein light chain DYNLRB1, as demonstrated by yeast two-hybrid, co-immunoprecipitation, and pull-down studies. Unlike Rab6A which preferentially binds DYNLRB1 in the GTP-bound state, RAB6B (and Rab6A') associates preferentially with DYNLRB1 in the GDP-bound state. DYNLRB1 co-localizes with RAB6B isoforms at the Golgi apparatus. |
Yeast two-hybrid, co-immunoprecipitation, pull-down assay, co-localization by fluorescence microscopy |
Cell motility and the cytoskeleton |
High |
18044744
|
| 2013 |
RAB6B physically interacts with the outer mitochondrial membrane protein GDAP1 (mutated in Charcot-Marie-Tooth disease), placing RAB6B in a vesicle-organelle trafficking complex that may participate in mitochondrial movement within the cell. |
Co-immunoprecipitation/pull-down (interaction identified in GDAP1 silencing study) |
Neurobiology of disease |
Medium |
23542510
|
| 2021 |
RAB6B is expressed in primary mouse macrophages where it localizes to the Golgi complex. Knockdown of Rab6b reduced TNF secretion by M. bovis BCG-infected macrophages without affecting Tnf mRNA or intracellular TNF protein levels, indicating RAB6B promotes post-translational trafficking and secretion of TNF in macrophages. |
siRNA knockdown, ELISA, qRT-PCR, Western blot, immunofluorescence/confocal microscopy |
Immunology and cell biology |
Medium |
34555867
|
| 2022 |
Double knockout of RAB6A/A' and RAB6B in radial glial cells impairs apical localization of the apical determinant Crumbs3 (CRB3) and causes retraction of the apical process, leading to delamination and ectopic division of apical radial glia. RAB6+ post-Golgi vesicles move toward microtubule minus ends in an apical direction in a dynein-dependent manner, establishing a RAB6-dynein-LIS1 pathway for Golgi-to-apical-surface transport. |
Double KO mice/in utero electroporation, in situ subcellular live imaging, immunofluorescence, genetic epistasis with dynein activator LIS1 KO |
EMBO reports |
High |
35979738
|
| 2023 |
The crystal structure of RAB6B in complex with the Rab6-binding domain of ELKS1 was solved, revealing that a C-terminal segment of ELKS1 forms a helical hairpin to recognize RAB6B through a unique binding mode. ELKS1 undergoes liquid-liquid phase separation (LLPS) that allows it to compete with other RAB6 effectors, accumulate RAB6B-coated liposomes, recruit RAB6B-coated vesicles to vesicle-releasing sites, and promote vesicle exocytosis. |
X-ray crystallography (co-crystal structure), in vitro reconstitution of LLPS, liposome binding assays, live-cell imaging of vesicle exocytosis |
The Journal of biological chemistry |
High |
37172719
|
| 2023 |
Epigenetic suppression of PGC1α in BRAF-inhibitor-resistant melanomas reduces RAB6B and RAB27A expression. Statin (HMGCR inhibitor) treatment blocks cell growth by lowering RAB6B and RAB27A prenylation, which reduces their membrane association and impairs integrin localization and downstream integrin-FAK signaling. Re-expression of both RAB6B and RAB27A together reverses statin vulnerability. |
Pharmacological inhibition, re-expression rescue experiments, Western blot for membrane fractionation, cell growth assays |
Nature communications |
Medium |
37277330
|
| 2024 |
CNS-specific Rab6a/b double knockout mice exhibit severe neocortical and cerebellar dysplasia. In cultured Rab6a/b DKO neurons, synaptic vesicle precursors (SVPs) abnormally accumulate adjacent to the Golgi apparatus, leading to defects in axonal extension and loss of axon-dendrite polarity. Rab6 DKO also causes significant lysosome expansion in neuronal soma, demonstrating that RAB6-mediated polarized transport of SVPs from the Golgi is essential for neuronal polarization and brain development. |
CNS-specific double knockout mice, live-cell imaging of vesicle trafficking, immunofluorescence, electron microscopy |
The Journal of neuroscience |
High |
38830762
|
| 2019 |
miR-4268 directly targets RAB6B mRNA in gastric cancer cells. Silencing of RAB6B phenocopies miR-4268 overexpression, inhibiting cell proliferation and G1/S transition via suppression of AKT/JNK signaling pathways and modulation of Cyclin D1 and CDK4. |
Luciferase reporter assay (direct targeting), siRNA knockdown, cell cycle analysis, Western blot for AKT/JNK pathway |
Cancer gene therapy |
Medium |
31303644
|
| 2023 |
miR-6216 directly targets RAB6B and negatively regulates its expression. Overexpression of miR-6216 inhibited neural stem cell (NSC) proliferation, while overexpression of RAB6B promoted NSC proliferation, placing RAB6B as a positive regulator of NSC proliferation downstream of miR-6216. |
miRNA overexpression, RAB6B overexpression, NSC proliferation assays |
Neuroscience research |
Low |
37059126
|
| 2017 |
RAB6B was identified as a protein that co-immunoprecipitates with CEA (carcinoembryonic antigen) in LoVo colon cancer cells, suggesting a physical interaction between RAB6B and CEA. |
Co-immunoprecipitation followed by LC-MS/MS |
Radiation oncology journal |
Low |
28881503
|